In response to events in Japan as a result of the Tohoku Kanto Earthquake and tsunami that devastated Japan's north east coastline region, GlaxoSmithKline (GSK) is supporting the ongoing relief efforts by working with the Japanese authorities, the Japan Pharmaceutical Manufacturers Association and local NGOs to assist medical support and pharmaceutical donation needs.
As part of the disaster relief program, GSK is donating ¥200 million (approx £1.5million) to the Japanese Red Cross to support the immediate efforts to supply clean water, blankets and food supplies.
The company is also donating cold medicines and oral care products worth ¥ 80 million (approx £600,000) following requests for this type of self-medication products from the authorities.
We are continuing to watch the situation closely and will provide additional support as the situation evolves. GSK is committed to supporting reconstruction efforts as much as possible.
The health and safety of all of the company's staff based in Japan, particularly those working in the Tohoku region, was accounted for shortly after the earthquake and we continue to offer help and support to all our employees affected by this disaster.
GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.